Head and neck cancers, but not benign lesions, express interleukin-4 receptors in situ.
Ravi Mehrotra, Raj K. Puri(Integrated BioTherapeutics (United States)), Frederick Varricchio(Rutgers, The State University of New Jersey), Syed R. Husain(Center for Biologics Evaluation and Research)
Cited by 12
Related Papers
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
|Nature Biotechnology|2006|2.2k
The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016
|The Lancet Global Health|2018|530
The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016
|The Lancet Oncology|2018|488